{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-069285","form_type":"8-K","ticker":"QTTB","cik":"0001661998","company_name":"Q32 Bio Inc.","filed_at":"2024-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.017491+00:00","generated_at":"2026-06-04T17:21:45.758017+00:00","sec_items":["5.07"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Homology stockholders approve all merger-related proposals with Q32 Bio","bullets":["Stock Issuance Proposal passed: 35M for, 4.2M against, 9.3M broker non-votes.","Authorized shares increased to 400M, and reverse stock split (1:10 to 1:30) approved.","2024 Stock Option Plan and ESPP approved; Merger compensation advisory also passed.","Adjournment proposal approved but not needed as all key proposals passed.","Special Meeting had 48.6M shares present (83.6% of outstanding)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-069285","json":"https://secwatch.observer/filing/0001193125-24-069285.json","markdown":"https://secwatch.observer/filing/0001193125-24-069285.md","text":"https://secwatch.observer/filing/0001193125-24-069285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/0001193125-24-069285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/d806902d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T17:21:45.758017+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"287ce12a72f8968c0c2e691d19c94130d6fbfcd6","claim":"Q32 Bio Inc. shareholders approved Advisory, non-binding approval of certain compensation arrangements for named executive officers in connection with the Merger at the 2024-03-15 meeting.","evidence_excerpt":"Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 33,917,653 4,789,759 622,700 9,271,737","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/0001193125-24-069285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"3f71f6e0490c20a1f0e8812381b1f7456491b0d7","claim":"Q32 Bio Inc. shareholders approved Amendment to the Restated Certificate of Incorporation to effect a reverse stock split at a ratio ranging from 1-for-10 to 1-for-30 at the 2024-03-15 meeting.","evidence_excerpt":"Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 43,418,119 5,081,292 102,438 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/0001193125-24-069285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"47ed22112568554ba17fad226d09ed05b8cde025","claim":"Q32 Bio Inc. shareholders approved Amendment to the Restated Certificate of Incorporation to increase the number of authorized shares of common stock to 400,000,000 at the 2024-03-15 meeting.","evidence_excerpt":"Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 42,910,808 5,634,844 56,197 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/0001193125-24-069285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"649833f9f71b9008f1fb8c35f006e414a16a9084","claim":"Q32 Bio Inc. shareholders approved 2024 Employee Stock Purchase Plan at the 2024-03-15 meeting.","evidence_excerpt":"Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 28,097,015 11,039,000 194,097 9,271,737","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/0001193125-24-069285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"8b0201ac368aa97e75eadb06d98e7480b36140d7","claim":"Q32 Bio Inc. shareholders approved Adjournment of the Special Meeting, if necessary, to solicit additional proxies at the 2024-03-15 meeting.","evidence_excerpt":"Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 42,818,421 3,172,749 2,610,679 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/0001193125-24-069285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"949e1e54b7c93fee5fc94be9d628a821bf2944dc","claim":"Q32 Bio Inc. shareholders approved 2024 Stock Option and Incentive Plan at the 2024-03-15 meeting.","evidence_excerpt":"Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 25,536,544 13,627,863 165,705 9,271,737","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/0001193125-24-069285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-15"}],"fact_type":"shareholder_vote"},{"claim_id":"a48e7b1d87f23a14b3d810b89bae19c3c8640fc2","claim":"Q32 Bio Inc. shareholders approved Issuance of shares of common stock of Homology to stockholders of Q32 Bio Inc. pursuant to the terms of the Agreement and Plan of Merger at the 2024-03-15 meeting.","evidence_excerpt":"Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 35,052,562 4,241,901 35,649 9,271,737","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/0001193125-24-069285-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"merger approval"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-03-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}